"Delivering new potential treatment options exemplifies Onyx and Amgen's commitment to advancing the care of patients with multiple myeloma," said Pablo J. Cagnoni, M.D., president, Onyx ...
Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease WorseningResults to Form Basis of Regulatory Filings Beginning in 1H 2015 The safety profile observed in this study is consistent ...
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition ...
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug. 4, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results